Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Change in Cash: 2023-2025

Historic Change in Cash for CG Oncology (CGON) over the last 3 years, with Sep 2025 value amounting to $30.5 million.

  • CG Oncology's Change in Cash rose 67.21% to $30.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 94.77%. This contributed to the annual value of $248.8 million for FY2024, which is 411.48% up from last year.
  • As of Q3 2025, CG Oncology's Change in Cash stood at $30.5 million, which was up 213.68% from -$26.8 million recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Change in Cash ranged from a high of $213.7 million in Q4 2024 and a low of -$215.6 million during Q1 2025.
  • Over the past 3 years, CG Oncology's median Change in Cash value was -$2.0 million (recorded in 2023), while the average stood at -$3.9 million.
  • Per our database at Business Quant, CG Oncology's Change in Cash soared by 10,745.59% in 2024 and then slumped by 411.55% in 2025.
  • Over the past 3 years, CG Oncology's Change in Cash (Quarterly) stood at -$2.0 million in 2023, then skyrocketed by 10,745.59% to $213.7 million in 2024, then soared by 67.21% to $30.5 million in 2025.
  • Its Change in Cash was $30.5 million in Q3 2025, compared to -$26.8 million in Q2 2025 and -$215.6 million in Q1 2025.